The Family Foundation, along with 49 other pro-life leaders, released a letter calling on FDA Commissioner nominee Dr. Heidi Overton to commit to restoring the safeguards governing mifepristone that existed before the Biden administration. Due to the Biden administration, the in person dispensing requirement has been lifted. This means abortion death pills can be shipped through the mail, violating the laws of pro-life states.
The letter explains why the FDA should not allow this policy to continue:
“First, there are serious concerns about the safety of the drug. As just one example, a recent study found that nearly 11% of women taking mifepristone have a serious “adverse event” within 45 days of taking it.”
“Second, the permissiveness of the current policy is increasing the risk of abuse, especially by men who seek to force women to have abortions without their consent or knowledge. By allowing mifepristone to be obtained without an in-person medical visit, the current FDA policy makes it more difficult to screen vulnerable women outside the presence of potential abusers.”
“Third, mail-order abortion is undermining state laws enacted to protect unborn life and women.”
The letter ends by saying “American mothers and babies need an FDA that defends them both in word and deed.”
“We therefore call on Dr. Heidi Overton and the Trump administration to restore meaningful safeguards for mifepristone immediately while the FDA completes its review, and to end policies that have enabled abortion drugs to be distributed through the mail without adequate medical oversight.”